Related Experiment Videos
Improving enzymes for cancer gene therapy
L P Encell1, D M Landis, L A Loeb
1Department of Pathology, University of Washington School of Medicine, Seattle, 98195-7705, USA.
Nature Biotechnology
|March 3, 1999
Summary
Enzyme engineering advances cancer gene therapy by creating tailored enzymes. These novel enzymes can enhance tumor prodrug activation and chemotherapy sensitization, while also protecting normal tissues from drug toxicity.
Area of Science:
- Biotechnology
- Molecular Biology
- Cancer Genetics
Background:
- Enzyme engineering is crucial for developing advanced cancer gene therapy strategies.
- Tailoring enzymes involves creating and selecting mutants from large libraries with random substitutions in catalytic domains.
Purpose of the Study:
- To review novel enzymes for cancer gene therapy.
- To discuss enzyme mutations for enhanced tumor ablation and host tissue protection.
Main Methods:
- Review of existing literature on enzyme engineering for cancer gene therapy.
- Analysis of gene mutations for prodrug activation, tumor sensitization, and tissue protection.
Main Results:
- Engineered enzymes can enhance prodrug activation and tumor sensitization to chemotherapy.
- Mutant enzymes can increase resistance of normal tissues, like bone marrow, to chemotherapeutic agents.
Conclusions:
- Enzyme engineering offers a feasible approach for tailored cancer gene therapy.
- Mutant enzymes hold potential for both targeting tumors and protecting healthy tissues.